31.03.2015 23:53:02
|
Landec Q3 Profit Meets Estimate
(RTTNews) - Landec Corp. (LNDC) reported net income for the third quarter of $3.8 million or $0.14 per share, compared to $6.4 million or $0.24 per share for the year-ago quarter.
Revenues for the third quarter rose 10% to $138.5 million from $126.4 million a year earlier, mainly due to a 21% increase in revenues in Apio's value-added business, which includes its Eat Smart fresh-cut specialty packaged vegetable business, Apio Cooling and Apio Packaging.
Analysts polled by Thomson Reuters expected the company to earn $0.14 per share on revenue of $135.73 million for the third quarter.
Looking forward to the fourth quarter, the company forecasts revenues of $130.0 million to $135.0 million and earnings per share of $0.18 to $0.20. Analysts currently expect the company to earn $0.20 per share on revenue of $127,20 million for the fourth quarter.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Lifecore Biomedicalmehr Nachrichten
20:05 |
NASDAQ-Handel NASDAQ Composite zeigt sich am Dienstagnachmittag schwächer (finanzen.at) | |
18:02 |
Dienstagshandel in New York: NASDAQ Composite präsentiert sich schwächer (finanzen.at) | |
16:03 |
Börse New York: NASDAQ Composite beginnt Dienstagshandel im Minus (finanzen.at) | |
06.01.25 |
Montagshandel in New York: NASDAQ Composite schlussendlich mit grünen Vorzeichen (finanzen.at) | |
06.01.25 |
Montagshandel in New York: NASDAQ Composite liegt im Plus (finanzen.at) | |
06.01.25 |
Starker Wochentag in New York: NASDAQ Composite am Montagmittag mit Gewinnen (finanzen.at) | |
06.01.25 |
Aufschläge in New York: NASDAQ Composite beginnt Sitzung weit in der Gewinnzone (finanzen.at) | |
03.01.25 |
Handel in New York: NASDAQ Composite zeigt sich zum Handelsende fester (finanzen.at) |
Analysen zu Lifecore Biomedicalmehr Analysen
Aktien in diesem Artikel
Lifecore Biomedical | 6,50 | -10,34% |